7M66

Targeting Enterococcus faecalis HMG-CoA reductase with a novel non-statin inhibitor

7M66 の概要

• エントリーDOI: 10.2210/pdb7m66/pdb
• 関連するPDBエントリー: 7M1Z 7M3H
• 分子名称: Hydroxymethylglutaryl-CoA reductase, degradative, SULFATE ION, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... (7 entities in total)
• 機能のキーワード: antibiotic, bacterial, hmg-coa reductase, antimicrobial protein
• 由来する生物種: Enterococcus faecalis (Streptococcus faecalis)
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 186876.32

構造登録者

Bose, S.,Steussy, C.N. (登録日: 2021-03-25, 公開日: 2022-09-28, 最終更新日: 2024-05-22)

主引用文献

Bose, S.,Steussy, C.N.,Lopez-Perez, D.,Schmidt, T.,Kulathunga, S.C.,Seleem, M.N.,Lipton, M.,Mesecar, A.D.,Rodwell, V.W.,Stauffacher, C.V.
Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor.
Commun Biol, 6:360-360, 2023

PubMed Abstract: HMG-CoA reductase (HMGR), a rate-limiting enzyme of the mevalonate pathway in Gram-positive pathogenic bacteria, is an attractive target for development of novel antibiotics. In this study, we report the crystal structures of HMGR from Enterococcus faecalis (efHMGR) in the apo and liganded forms, highlighting several unique features of this enzyme. Statins, which inhibit the human enzyme with nanomolar affinity, perform poorly against the bacterial HMGR homologs. We also report a potent competitive inhibitor (Chembridge2 ID 7828315 or compound 315) of the efHMGR enzyme identified by a high-throughput, in-vitro screening. The X-ray crystal structure of efHMGR in complex with 315 was determined to 1.27 Å resolution revealing that the inhibitor occupies the mevalonate-binding site and interacts with several key active site residues conserved among bacterial homologs. Importantly, 315 does not inhibit the human HMGR. Our identification of a selective, non-statin inhibitor of bacterial HMG-CoA reductases will be instrumental in lead optimization and development of novel antibacterial drug candidates.

PubMed: 37012403
DOI: 10.1038/s42003-023-04639-y

実験手法

X-RAY DIFFRACTION (2.25 Å)